Search

Author/Creator Angelo, Maria-Genalin

2. Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Issue 11 (1st November 2016)

Authors:
Willame, Corinne; Rosillon, Dominique; Zima, Julia; Angelo, Maria-Genalin; Stuurman, Anke L.; Vroling, Hilde; Boggon, Rachael; Bunge, Eveline M.; Pladevall-Vila, Manel; Baril, Laurence
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 12:Issue 11(2016)
Page Start:
2862
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial. Issue 12 (1st December 2016)

Authors:
Lehtinen, Matti; Eriksson, Tiina; Apter, Dan; Hokkanen, Mari; Natunen, Kari; Paavonen, Jorma; Pukkala, Eero; Angelo, Maria-Genalin; Zima, Julia; David, Marie-Pierre; Datta, Sanjoy; Bi, Dan; Struyf, Frank; Dubin, Gary
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 12:Issue 12(2016)
Page Start:
3177
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Strategies for continuous evaluation of the benefit–risk profile of HPV-16/18-AS04-adjuvanted vaccine. (November 2014)

Authors:
Angelo, Maria-Genalin; Taylor, Sylvia; Struyf, Frank; Tavares Da Silva, Fernanda; Arellano, Felix; David, Marie-Pierre; Dubin, Gary; Rosillon, Dominique; Baril, Laurence
Journal:
Expert review of vaccines
Issue:
Volume 13:Number 11(2014)
Page Start:
1297
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗